It is the policy of Cheek and Scott Drugs, Inc. not to discriminate on the basis of race, color, national origin, age, disability, and sex.  Cheek and Scott, Inc. has adopted an internal grievance procedure providing for prompt and equitable resolution of complaints alleging any action prohibited by Section 504 of the Rehabilitation Act of 1973 (29 U.S.C. 794) of the U.S. Department of Health and Human Services regulations implementing the Act.  Section 504 prohibits discrimination on the basis of race, color, national origin, age, disability, and sex in any program or activity receiving Federal financial assistance. The Law and Regulations may be examined in the office of Joseph Chamberlain, Clinical Director (386-362-2591), who has been designated to coordinate the efforts of Cheek and Scott Drugs, Inc. to comply with Section 504.

Any person who believes she or he has been subjected to discrimination on this basis may file a grievance under this procedure. It is against the law for Cheek and Scott, Inc. to retaliate against anyone who files a grievance or cooperates in the investigation of a grievance.


Cheek and Scott Drugs, Inc. will make appropriate arrangements to ensure that disabled persons are provided other accommodations, if needed, to participate in this grievance process. Such arrangements may include, but are not limited to, providing interpreters for the deaf, providing taped cassettes of material for the blind, or assuring a barrier-free location for the proceedings. The Section 504 Coordinator will be responsible for such arrangements.